Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC

Patrick N. Song(University of Alabama at Birmingham), Anna G. Sorace(University of Alabama at Birmingham)
Scientific Reports
February 14, 2024
Cited by 12


Related Papers